Definition
Erythroblastosis fetalis is a potentially life-threatening blood disorder in a fetus or newborn infant. This article provides a general overview. For more detailed information see the specific disorder:
Alternative Names
Hemolytic disease of the newbornCauses, incidence, and risk factors
Erythroblastosis fetalis develops in an unborn infant when the mom and the baby have different blood types. The mother produces substances called antibodies that attack the developing baby's red blood cells.
The most common form of erythroblastosis fetalis is ABO incompatibility, which can vary in its severity.
The less common form is called Rh incompatibility, which more often causes a very severe anemia in the baby.
Symptoms
Symptoms in a newborn baby may include:
- Anemia
- Enlarged liver or spleen
- Generalized swelling
- Newborn jaundice
Signs and tests
Specific tests depend on the type of erythroblastosis, but may include:
- Complete blood count
- Bilirubin level
- Blood typing
Treatment
After birth, depending on the severity, a transfusion usually needs to be performed.
For specific treatment information see:
Support Groups
Expectations (prognosis)
The severity of this condition can vary widely. In some instances, the baby has no symptoms of the disease. In other cases, it can lead to death of the baby before or shortly after birth. It can be treated before birth by intrauterine transfusion.
Complications
Complications depend on the specific type of erythroblastosis fetalis.
Calling your health care provider
Prevention
The most severe form of this disease, Rh incompatibility, can be prevented if the mother takes a medicine called RhoGAM at certain times during and after pregnancy. If you have had a baby with this disease, be sure to talk with your doctor if you plan on having another baby.
Images
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program is an independent audit to verify that A.D.A.M. follows rigorous
standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and
services. Learn more about A.D.A.M.'s editorial
policy, editorial
process, and privacy
policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch.)
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment
of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions.
Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those
other sites.
©1997-2008 A.D.A.M., Inc. Any duplication or
distribution of the information contained herein is strictly prohibited.